Alzheimer Mechanisms and Therapeutic Strategies

Huang, Yadong, Mucke, Lennart·2012·Cell

Cited by (1,005)

Items 901–1,000 of 1,005

  1. MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer’s disease mice via regulation of HMGB1/NF-κB signaling
    Peng Shao · 2021 · Brain Research
  2. Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer’s disease (AD) mice and human AD brains
    Zhihong Bian, Toru Yamashita, Xiaowen Shi, Tian Feng, Haibo Yu, Xiao Feng Hu, Xinran Hu, Yuting Bian, Hongming Sun, Koh Tadokoro et al. · 2021 · Brain Research
  3. Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis
    Sadequl Islam, Yang Sun, Yuan Gao, Tomohisa Nakamura, A. Noorani, Tong Li, P. Wong, Noriyuki Kimura, E. Matsubara, K. Kasuga et al. · 2022 · Journal of Neuroscience
  4. Protein structure from the essential amino acids to the 3D structure
    2019 · Biointerface Research in Applied Chemistry
  5. Autophagy Regulation Influences β-Amyloid Toxicity in Transgenic Caenorhabditis elegans
    Hong‐Ru Lin, Yehui Gao, Chen Zhang, Botian Ma, Mengchen Wu, Xianghuan Cui, Hongbing Wang · 2022 · Frontiers in Aging Neuroscience
  6. Development and Evaluation of Some Molecular Hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer’s Disease
    Digambar Kumar Waiker, Akash Verma, Poorvi Saraf, Gajendra T.A., Sairam Krishnamurthy, Rameshwar Nath Chaurasia, Sushant Kumar Shrivastava · 2023 · ACS Omega
  7. Comprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer’s Disease from 2004 to 2022
    Rui Wang, Yi Zhu, Lan-Fang Qin, Zhiguo Xu, Xi-Ren Gao, Chongbin Liu, Guo‐Tong Xu, Yizhu Chen · 2023 · Dementia and Geriatric Cognitive Disorders
  8. Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
    Carla Fonseca, Miren Ettcheto, Joana Bicker, Maria José Fernandes, Amílcar C. Falcão, Antoni Camins, Ana C. Fortuna · 2023 · Ageing Research Reviews
  9. Past, present, and future of deep transcranial magnetic stimulation: A review in psychiatric and neurological disorders
    Jin-Ling Cheng, Cheng Tan, Hui-Yu Liu, Dongmiao Han, Zicai Liu · 2023 · World Journal of Psychiatry
  10. Tanshinone IIA, the key compound in Salvia miltiorrhiza, improves cognitive impairment by upregulating Aβ-degrading enzymes in APP/PS1 mice
    Xiao-Qi Liu, Hu Tian, Guangliang Wu, Lijun Qiao, Ye-Feng Cai, Qi Wang, Shijie Zhang · 2023 · International Journal of Biological Macromolecules
  11. Endostatin Level in Cerebrospinal Fluid of Patients with Alzheimer's Disease
    Romain Salza, Jean‐Baptiste Oudart, Laurent Ramont, François‐Xavier Maquart, Serge Bakchine, H. Thoannes, Sylvie Ricard‐Blum · 2015 · Journal of Alzheimer s Disease
  12. Aβ induces PUMA activation: a new mechanism for Aβ-mediated neuronal apoptosis
    Jie Feng, Chengbo Meng, Da Xing · 2014 · Neurobiology of Aging
  13. Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease
    Silvia Caioli, Cinzia Severini, Teresa Ciotti, Fulvio Florenzano, Domenico Pimpinella, Pamela Petrocchi Passeri, Gianfranco Balboni, Patrizio Polisca, Roberta Lattanzi, Robert Nisticò et al. · 2016 · Neuropharmacology
  14. Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues
    Rosanna Caliandro, Alessandro Pesaresi, Luca Cariati, Antonio Procopio, Manuela Oliverio, Doriano Lamba · 2018 · Journal of Enzyme Inhibition and Medicinal Chemistry
  15. Physical & mental activities enhance the neuroprotective effect of vinpocetine & coenzyme Q10 combination against Alzheimer & bone remodeling in rats
    Azza A. Ali, Dina Moustafa Abo El-Ella, Soad Z. El‐Emam, Amal Said Shahat, Rehab M. El‐Sayed · 2019 · Life Sciences
  16. Amyloid-β Peptides Disrupt Interactions Between VAMP-2 and SNAP-25 in Neuronal Cells as Determined by FRET/FLIM
    Nidhi Sharda, Thomas Pengo, Zengtao Wang, Karunya K. Kandimalla · 2020 · Journal of Alzheimer s Disease
  17. Aftins Increase Amyloid-β42, Lower Amyloid-β38, and Do Not Alter Amyloid-β40 Extracellular Production in vitro: Toward a Chemical Model of Alzheimer's Disease?
    Arnaud Hochard, Nassima Oumata, Karima Bettayeb, Olfa Gloulou, Xavier Fant, Émilie Durieu, Nelly Buron, Mathieu Porceddu, Annie Borgne‐Sanchez, Hervé Galons et al. · 2013 · Journal of Alzheimer s Disease
  18. An Alzheimer’s-disease-protective APOE mutation
    Zalocusky, Kelly A., Nelson, Maxine R., Huang, Yadong · 2019 · Nature Medicine
  19. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus
    Xue Pan, Long Zz, Jiang Gg, Wang Lp, Bian Cm, Wang Yl, M.F. Chen, Wei Li · 2022 · Neurochemistry International
  20. Human iPSC-derived microglial cells protect neurons from neurodegeneration in long-term cultured adhesion brain organoids
    Chen, Xianwei, Sun, Guoqiang, Feng, Lizhao, Tian, E, Shi, Yanhong · 2025 · Communications Biology
  21. Microglia-derived nanovesicles synchronize macroautophagy and chaperone-mediated autophagy for Alzheimer’s disease therapy
    Min Li, Shuang Chen, Rong Guo, Yang Wang, Mingrui Yang, Yingke Liu, Qiang Zhang, Shiyu Zhu, Jiaxin Li, Fang Chen et al. · 2025 · Signal Transduction and Targeted Therapy
  22. Genetic Determinants of “Cognitive Impairment, No Dementia”
    Joseph B. Dubé, Christopher T. Johansen, John F. Robinson, Joan Lindsay, Vladimir Hachinski, Robert Alexander Hegele · 2013 · Journal of Alzheimer s Disease
  23. The pro-apoptotic protein Bmf co-operates with Bim and Puma in neuron death induced by β-amyloid or NGF deprivation
    Rumana Akhter, Suraiya Saleem, Akash Saha, Subhas Chandra Biswas · 2018 · Molecular and Cellular Neuroscience
  24. Heme Oxygenase 1 Induces Tau Oligomer Formation and Synapse Aberrations in Hippocampal Neurons
    Zizhen Si, Xidi Wang, Zhujun Zhang, Jinxin Wang, Jihong Li, Jing Li, Ling Li, Yuanxin Li, Yahui Peng, Chongran Sun et al. · 2018 · Journal of Alzheimer s Disease
  25. Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach
    Yan-Jie Qu, Rong-Rong Zhen, Limin Zhang, Chao Gu, Lei Chen, Xiao Peng, Bing Hu, Hong‐Mei An · 2020 · BMC Complementary Medicine and Therapies
  26. Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review
    Nobutaka Masuoka, Chenxu Lei, Haowei Li, Tatsuhiro Hisatsune · 2021 · Nutrients
  27. Therapeutic anti‐amyloid β antibodies cause neuronal disturbances
    Utpal Kumar Adhikari, Rizwan Hasan Khan, Meena Mikhael, Rachelle Balez, Monique Antoinette David, David Anthony Mahns, John Hardy, Mourad Tayebi · 2022 · Alzheimer s & Dementia
  28. APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release
    Nicole Koutsodendris, Jessica R. Blumenfeld, Ayushi Agrawal, Michela Traglia, Oscar Yip, Antara T. Rao, Min Joo Kim, Maxine R. Nelson, Yung-Hua Wang, Brian P. Grone et al. · 2023 · Cell Reports
  29. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models
    Julie Kelly, Noreen T. Boyle, Natalie Cole, Gillian R. Slator, Maria Alessandra Colivicchi, Chiara Stefanini, Oliviero L. Gobbo, Gaia Scalabrino, Sinéad M. Ryan, Marwa Elamin et al. · 2014 · Neuropharmacology
  30. Alterations of membrane protein expression in red blood cells of Alzheimer's disease patients
    György Várady, Edit Szabó, Ágnes Fehér, Adrienne Németh, Boglárka Zámbó, Magdolna Pákáski, Zoltán Janka, Balázs Sarkadi · 2015 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  31. A novel approach for integrative studies on neurodegenerative diseases in human brains
    Panos Theofilas, Lívia Polichiso, Xuehua Wang, Luzia Carreira Lima, Ana Tereza Di Lorenzo Alho, Renata Elaine Paraízo Leite, Cláudia Kimie Suemoto, Carlos Augusto Pasqualucci, Wilson Jacob Filho, Helmut Heinsen et al. · 2014 · Journal of Neuroscience Methods
  32. Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation
    Ryoichi Kimura, David MacTavish, Jing Yang, David A. Westaway, Jack H. Jhamandas · 2016 · Molecular Neurobiology
  33. In silico drug repositioning for the treatment of Alzheimer's disease using molecular docking and gene expression data
    Hongbo Xie, Haixia Wen, Mingze Qin, Jie Xia, Denan Zhang, Lei Liu, Бо Лю, Qiuqi Liu, Qing Jin, Xiujie Chen · 2016 · RSC Advances
  34. Reducing expression of synapse-restricting protein Ephexin5 ameliorates Alzheimer’s-like impairment in mice
    Gabrielle L. Sell, Thomas B. Schaffer, Seth S. Margolis · 2017 · Journal of Clinical Investigation
  35. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy
    Francesca Rossi, Philippine C. Geiszler, Weina Meng, Matthew R. Barron, Malcolm J. W. Prior, Anna Herd-Smith, Andrea Loreto, Maria Yanez Lopez, Henryk Faas, Marie‐Christine Pardon et al. · 2017 · Behavioural Brain Research
  36. Alternative hypotheses related to Alzheimer’s disease
    Veronika Cubinkova, Bernadeta Valachova, Ivana Uhrinova, Veronika Brezováková, Tomáš Smolek, Santosh Jadhav, Norbert Žilka · 2018 · Bratislavské lekárske listy/Bratislava medical journal
  37. l -Dopa and dopamine conjugated naphthalenediimides modulate amyloid β toxicity
    Madhu Ramesh, Pandeeswar Makam, Chandrashekhar Voshavar, Harshavardhan Khare, Kolla Rajasekhar, Suryanarayanarao Ramakumar, Thimmaiah Govindaraju · 2018 · Organic & Biomolecular Chemistry
  38. Orexin-A exacerbates Alzheimer’s disease by inducing mitochondrial impairment
    Maoyu Li, Yao Meng, Bingcong Chu, Yang Shen, Xinhong Xue, Chaoyuan Song, Xiangtian Liu, Mao Ding, Xi Cao, Ping Wang et al. · 2020 · Neuroscience Letters
  39. Protective Role Of Apigenin Against Aβ25-35 Toxicity Via Inhibition Of Mitochondrial Cytochrome C Release
    Farnaz Nikbakht, Yasaman Khadem, Sobhan Haghani, Hadiseh Hoseininia, Moein Sadat Alireza, Paria Hashemi, Nida Jamali · 2019 · Basic and Clinical Neuroscience Journal
  40. Intercellular adhesion molecule 1: Recent findings and new concepts involved in mammalian spermatogenesis
    Dolores D. Mruk, Xiang Xiao, Marta Łydka, Michelle Li, Barbara Bilińska, C. Yan Cheng · 2013 · Seminars in Cell and Developmental Biology
  41. Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer’s Disease Cohorts
    Alzheimer’s Disease Neuroimaging Initiative, Zixuan Wang, Hui-Fu Wang, Lin Tan, Jinyuan Liu, Yu Wan, Fu-Rong Sun, Meng‐Shan Tan, Chen-Chen Tan, Teng Jiang et al. · 2016 · Molecular Neurobiology
  42. Electroacupuncture Improves Synaptic Function in SAMP8 Mice Probably via Inhibition of the AMPK/eEF2K/eEF2 Signaling Pathway
    Weiguo Dong, Wen-Dan Yang, Feifei Li, Wan-Qing Guo, Changhui Qian, Feng Wang, Changzhen Li, Lan Lin, Ruhui Lin · 2019 · Evidence-based Complementary and Alternative Medicine
  43. Gardenia jasminoides J.Ellis extract GJ-4 alleviated cognitive deficits of APP/PS1 transgenic mice
    Zang, Caixia, Liu, Hui, Shang, Junmei, Yang, Hanyu, Wang, Lu, Sheng, Chanjuan, Zhang, Zihong, Bao, Xiuqi, Yu, Yang, Yao, Xinsheng et al. · 2021 · Phytomedicine
  44. Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy
    Christina Dammers, Lothar Gremer, Philipp Neudecker, Hans‐Ulrich Demuth, Melanie Schwarten, Dieter Willbold · 2015 · PLoS ONE
  45. Gamma secretase inhibitors: a patent review (2013 - 2015)
    Kai Gu, Qi Li, Hongzhi Lin, Jie Zhu, Jun Mo, Siyu He, Xin Lü, Xueyang Jiang, Haopeng Sun · 2017 · Expert Opinion on Therapeutic Patents
  46. Overexpression of U1 snRNA induces decrease of U1 spliceosome function associated with Alzheimer’s disease
    Zhi Cheng, Yingchun Shang, Shan Gao, Tao Zhang · 2017 · Journal of Neurogenetics
  47. An Insight in Pathophysiological Mechanism of Alzheimer’s Disease and its Management Using Plant Natural Products
    Zeba Firdaus, Tryambak Deo Singh · 2020 · Mini-Reviews in Medicinal Chemistry
  48. Natural Food Supplements Reduce Oxidative Stress in Primary Neurons and in the Mouse Brain, Suggesting Applications in the Prevention of Neurodegenerative Diseases
    Miriam Bobadilla, Josune Garcı́a-Sanmartı́n, Alfredo Martı́nez · 2021 · Antioxidants
  49. Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
    Isaac G. Onyango, James P. Bennett, Gorazd Bernard Stokin · 2021 · Current Alzheimer Research
  50. Blood Transcript Biomarkers Selected by Machine Learning Algorithm Classify Neurodegenerative Diseases including Alzheimer’s Disease
    Carol J. Huseby, Elaine Delvaux, Danielle L. Brokaw, Paul D. Coleman · 2022 · Biomolecules
  51. Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
    Shuai Zhao, Ziqi Fan, Xinyi Zhang, Zheyu Li, Ting Shen, Kaicheng Li, Yaping Yan, Yunfeng Yuan, Jiali Pu, Jun Tian et al. · 2022 · Neurotherapeutics
  52. Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects
    Md. Fahim Faysal, Zerrouki Dehbia, Mehrukh Zehravi, Sherouk Hussein Sweilam, M. Akiful Haque, Kusuma Praveen Kumar, Rita Dadarao Chakole, Satish P. Shelke, Swapna Sirikonda, Mohamed H. Nafady et al. · 2024 · Neurochemical Research
  53. The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer’s disease
    Francesco Angelucci, Francesca Gelfo, Marco Fiore, Nicoletta Croce, Aleksander A. Mathé, Sergio Bernardini, Carlo Caltagirone · 2014 · Canadian Journal of Physiology and Pharmacology
  54. Protein structures in Alzheimer's disease: The basis for rationale therapeutic design
    Laia Montoliu‐Gaya, Sandra Villegas · 2015 · Archives of Biochemistry and Biophysics
  55. Stabilizing the monomeric amyloid-β peptide by tyrocidine A prevents and reverses amyloidogenesis without the accumulation of oligomers
    Gesi Wen, Wenjing Qin, Daoyuan Chen, Youqiao Wang, Xin Yue, Ziyi Liu, Yingnan Cao, Jun Du, Binhua Zhou, Xianzhang Bu · 2017 · Chemical Communications
  56. Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease
    Qiaohong Liu, Jia‐Jia Wu, Fan Li, Pei Cai, Xuelian Yang, Ling‐Yi Kong, Xiaobing Wang · 2017 · MedChemComm
  57. Presenilin-1 Targeted Morpholino Induces Cognitive Deficits, Increased Brain Aβ1−42 and Decreased Synaptic Marker PSD-95 in Zebrafish Larvae
    Laura Roesler Nery, Natália Eltz Silva, Raphaela Soares Fonseca, Mônica Ryff Moreira Roca Vianna · 2017 · Neurochemical Research
  58. Surprisingly high stability of the Aβ oligomer eliminating all-d-enantiomeric peptide D3 in media simulating the route of orally administered drugs
    Anne Elfgen, Beatrix Santiago‐Schübel, Lothar Gremer, Janine Kutzsche, Dieter Willbold · 2017 · European Journal of Pharmaceutical Sciences
  59. Research advances in the treatment of Alzheimer's disease with polysaccharides from traditional Chinese medicine
    Qin Liu, Shunchun Wang, Kan Ding · 2017 · Chinese Journal of Natural Medicines
  60. Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice
    Haobin Cai, Yijie Wang, Jiayang He, Tiantian Cai, Jun Wu, Jiansong Fang, Rong Zhang, Zhouke Guo, Li Guan, Qinkai Zhan et al. · 2017 · Oncotarget
  61. Rationale and methods for a multicenter clinical trial assessing exercise and intensive vascular risk reduction in preventing dementia (rrAD Study)
    Amanda N. Szabo‐Reed, Eric D. Vidoni, Ellen F. Binder, Jeffrey Murray Burns, C. Munro Cullum, William P. Gahan, Aditi Gupta, Linda Susan Hynan, Diana R. Kerwin, Heidi C. Rossetti et al. · 2019 · Contemporary Clinical Trials
  62. Dietary interventions and cognition of Alzheimer’s disease patients: a systematic review of randomized controlled trial
    Sophia Camargos Moreira, Ann Kristine Jansen, Flávia Moraes Silva · 2020 · Dementia & Neuropsychologia
  63. Inhibition of Piezo1/Ca2+/calpain signaling in the rat basal forebrain reverses sleep deprivation-induced fear memory impairments
    Tao Ma, Yingying Wang, Yan Lu, Long Feng, Yi Yang, Guan‐Hua Li, Chi Li, Yang Chu, Wei Wang, Hao Zhang · 2021 · Behavioural Brain Research
  64. Pseudo-peptide amyloid-β blocking inhibitors: molecular dynamics and single molecule force spectroscopy study
    Banafsheh Mehrazma, Morgan J. Robinson, Stanley K. A. Opare, Anahit Petoyan, Jennifer W. Lou, Francis T. Hane, Arvi Rauk, Zoya Leonenko · 2017 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  65. Alzheimer’s Disease: Dawn of a New Era?
    Amirrad, Farideh, Bousoik, Emira, Shamloo, Kiumars, Al-Shiyab, Hassan, Nguyen, Viet-Huong V., Montazeri Aliabadi, Hamidreza · 2017 · Journal of Pharmacy & Pharmaceutical Sciences
  66. Multifaceted neuroprotective approach of Trolox in Alzheimer's disease mouse model: targeting Aβ pathology, neuroinflammation, oxidative stress, and synaptic dysfunction
    Muhammad Tahir, Min Hwa Kang, Tae Ju Park, Jawad Ali, Kyonghwan Choe, Jun Sung Park, Myeong Ok Kim · 2024 · Frontiers in Cellular Neuroscience
  67. Inhibition of the cGAS–STING pathway via an endogenous copper ion-responsive covalent organic framework nanozyme for Alzheimer's disease treatment
    Haochen Zhang, Junlin Ya, Mengyu Sun, Xiubo Du, Jinsong Ren, Xiaogang Qu · 2025 · Chemical Science
  68. Advancements of the sFIDA method for oligomer‐based diagnostics of neurodegenerative diseases
    Andreas Kulawik, Henrike Heise, Christian Zafiu, Dieter Willbold, Oliver Bannach · 2018 · FEBS Letters
  69. Enhanced Clearance of Neurotoxic Misfolded Proteins by the Natural Compound Berberine and Its Derivatives
    P. Rusmini, Riccardo Cristofani, B. Tedesco, Veronica Ferrari, Elio Messi, Margherita Piccolella, Elena Casarotto, Marta Chierichetti, M.E. Cicardi, M. Galbiati et al. · 2020 · International Journal of Molecular Sciences
  70. Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer’s Disease or Mild Cognitive Impairment
    Lanlan Li, Yeying Yang, Qi Zhang, Jiao Wang, Jiehui Jiang, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Behavioural Neurology
  71. Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease
    Devashi Paliwal, Tim W. McInerney, Judy Pa, Russell Howard Swerdlow, Simon Easteal, Shea J. Andrews, for the Alzheimer’s Disease Neuroimaging Initiative · 2020 · Neurobiology of Aging
  72. Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer’s Disease
    Parisa Faraji, Hartmut Kühn, Shahin Ahmadian · 2024 · Journal of Molecular Neuroscience
  73. Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations
    Qin Fan, Bicheng Sun, Jie Chao · 2024 · Small Methods
  74. Biomarker-Driven Therapeutic Management of Alzheimer’s Disease: Establishing the Foundations
    Jeffrey L. Cummings, K. Zhong · 2013 · Clinical Pharmacology & Therapeutics
  75. Active immunotherapy for Alzheimer's disease
    Thomas Wısnıewskı · 2012 · The Lancet Neurology
  76. Overexpression of Heme Oxygenase 1 Impairs Cognitive Ability and Changes the Plasticity of the Synapse
    Lisha Li, Yahui Peng, Yang Hui, Shuai Zhang, You Lang Zhou, Dan Li, Jihong Li, Zizhen Si, Jing Li, Dayong Wang et al. · 2015 · Journal of Alzheimer s Disease
  77. Benefits of Deep Transcranial Magnetic Stimulation in Alzheimer Disease: Case Series
    K. Avirame, J. Stehberg, D. Todder · 2016 · Journal of ECT
  78. Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications
    Elissaios Karageorgiou, Keith A. Vossel · 2017 · Alzheimer s & Dementia
  79. Computational design of amyloid self-assembling peptides bearing aromatic residues and the cell adhesive motif Arg-Gly-Asp
    Sai Vamshi R. Jonnalagadda, Eirini Ornithopoulou, Asuka A. Orr, Estelle Mossou, V. Trevor Forsyth, Edward P. Mitchell, Matthew W. Bowler, Anna Mitraki, Phanourios Tamamis · 2017 · Molecular Systems Design & Engineering
  80. Hydrophobic Modification of Carboxyl-Terminated Polyamidoamine Dendrimer Surface Creates a Potent Inhibitor of Amyloid-β Fibrillation
    Ziyuan Wang, Xiaoyan Dong, Yan Ping Sun · 2018 · Langmuir
  81. The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system
    Daniela Maftei, Patrizia Ratano, Ilaria Fusco, Veronica Marconi, Silvia Squillace, Lucia Negri, Cinzia Severini, Gianfranco Balboni, Luca Steardo, Maria Rosanna Bronzuoli et al. · 2019 · Neuropharmacology
  82. Molecular and clinical insights into protein misfolding and associated amyloidosis
    Monu Pande, Ragini Srivastava · 2019 · European Journal of Medicinal Chemistry
  83. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors
    Weiwei Ma, Jingjing Bi, Chuanfang Zhao, Yangguang Gao, Guisheng Zhang · 2020 · Carbohydrate Research
  84. Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease
    Xian‐Le Bu, Shu‐Sheng Jiao, Yan Lian, Yan‐Jiang Wang · 2015 · Current Alzheimer Research
  85. Hydrogen peroxide detection with high specificity in living cells and inflamed tissues
    Lei Rong, Chi Zhang, Qi Lei, Ming‐Ming Hu, Jun Xiang Feng, Hong‐Bing Shu, Yi Liu, Xian‐Zheng Zhang · 2016 · Regenerative Biomaterials
  86. Failure in a population: Tauopathy disrupts homeostatic set-points in emergent dynamics despite stability in the constituent neurons
    James N. McGregor, Clayton A. Farris, Sahara Ensley, Aidan M Schneider, Leandro J. Fosque, Chao Wang, Elizabeth I. Tilden, Yuqi Liu, Jianhong Tu, Halla Elmore et al. · 2024 · Neuron
  87. Effects of 1950 MHz radiofrequency electromagnetic fields on Aβ processing in human neuroblastoma and mouse hippocampal neuronal cells
    Jeongyeon Park, Jong Hwa Kwon, Nam Kim, Kiwon Song · 2017 · Journal of Radiation Research
  88. A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease
    Suchitil Rivera-Marrero, Alberto Bencomo-Martínez, Erika Orta Salazar, Marquiza Sablón-Carrazana, Laura García-Pupo, Florencia Zoppolo, Florencia Arredondo, Rosina Dapueto, María Daniela Santi, Ingrid Kreimerman et al. · 2020 · Bioorganic & Medicinal Chemistry
  89. Tetrapeptide Ac-HAEE-NH2 Protects α4β2 nAChR from Inhibition by Aβ
    Evgeny P. Barykin, Aleksandra I. Garifulina, Anna P. Tolstova, Anastasia A. Anashkina, Alexei A. Adzhubei, Yuri V. Mezentsev, Irina V. Shelukhina, Sergey A. Kozin, Victor I. Tsetlin, Alexander А. Makarov · 2020 · International Journal of Molecular Sciences
  90. Strategies and Tools for Studying Microglial-Mediated Synapse Elimination and Refinement
    Raffaella Morini, Matteo Bizzotto, Fabio Perrucci, Fabia Filipello, Michela Matteoli · 2021 · Frontiers in Immunology
  91. Attenuative Effects of Fluoxetine and Triticum aestivum against Aluminum-Induced Alzheimer’s Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity
    Karema Abu‐Elfotuh, Ghada M. Ragab, Ahmad Salahuddin, Lubna Jamil, Ekram Nemr Abd Al Haleem · 2021 · Molecules
  92. Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer’s disease
    Mei-Yun Tang, Fredric A. Gorin, Pamela J. Lein · 2022 · Ageing and Neurodegenerative Diseases
  93. MAPK signaling and a mobile scaffold complex regulate AMPA receptor transport to modulate synaptic strength
    Frédéric J. Hoerndli, Penelope J. Brockie, Rui Wang, Jerry E. Mellem, Angy J. Kallarackal, Rachel L. Doser, Dayton M. Pierce, David M. Madsen, Andres Villu Maricq · 2022 · Cell Reports
  94. Plasma Core Alzheimer’s Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline
    Ming Ni, Zehua Zhu, Feng Gao, Linbin Dai, Xinyi Lv, Qiong Wang, Xingxing Zhu, Ji-Kui Xie, Yong Shen, Shi‐Cun Wang et al. · 2022 · ACS Chemical Neuroscience
  95. Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease
    Ying Chen, Weiting Zhang, Qi Li, Huanfang Xie, Shuaishuai Xing, Xin Lü, Weiping Lyu, Baichen Xiong, Yuanyuan Wang, Wei Qu et al. · 2024 · European Journal of Medicinal Chemistry
  96. 8-weeks aerobic exercise ameliorates cognitive deficit and mitigates ferroptosis triggered by iron overload in the prefrontal cortex of APPSwe/PSEN1dE9 mice through Xc−/GPx4 pathway
    Chaoyang Li, Kaiyin Cui, Xinyuan Zhu, Shufan Wang, Qing Yang, Guoliang Fang · 2024 · Frontiers in Neuroscience
  97. Biological Activity of sym-Triazines with Acetylcholine-like Substitutions as Multitarget Modulators of Alzheimer’s Disease
    Anthony J. Veloso, Ari M. Chow, Devjani Dhar, Derek W.F. Tang, Hashwin V. S. Ganesh, Svetlana N. Mikhaylichenko, Ian R. Brown, Kağan Kerman · 2013 · ACS Chemical Neuroscience
  98. Specific Triazine Herbicides Induce Amyloid-β 42 Production
    Erik Portelius, Émilie Durieu, Marion Bodin, Morgane Cam, Josef Pannee, Charlotte Leuxe, Aloïse M Mabondzo, Nassima Oumata, Hervé Galons, Jung Yeol Lee et al. · 2016 · Journal of Alzheimer s Disease
  99. Discovery of a novel multifunctional carbazole–aminoquinoline dimer for Alzheimer's disease: copper selective chelation, anti-amyloid aggregation, and neuroprotection
    Xiao Zhang, Ying Wang, Sheng-nan Wang, Qiu-he Chen, Yalin Tu, Xiaohong Yang, Jing-kao Chen, Jinwu Yan, Rongbiao Pi, Yan Wang · 2017 · Medicinal Chemistry Research
  100. A Novel Peroxidase Mimics and Ameliorates Alzheimer’s Disease-Related Pathology and Cognitive Decline in Mice
    Jia Xu, Kai Wang, Ye Yuan, Hui Li, Ruining Zhang, Shuwen Guan, Liping Wang · 2018 · International Journal of Molecular Sciences